JUSTIN CAMPBELL: Open Payments
NPI 1427237080 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 41 payments from 14 companies in 2025. Trend: 2023 $1,043 · 2024 $836 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| Abbott Laboratories | 5 | $103 |
| Novo Nordisk Inc | 5 | $103 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Radius Health, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, FARXIGA, Wegovy, AREXVY, JARDIANCE, Ozempic, Tymlos.
Industry payments across AL — which companies pay providers there.
